10X Genomics, Inc. (TXG)
17.89
+0.05
(+0.28%)
USD |
NASDAQ |
Dec 10, 14:26
10X Genomics EPS Diluted (Quarterly): -0.2189 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Omnicell, Inc. | 0.119 |
| American Shared Hospital Services | -0.0026 |
| Astrana Health, Inc. | 0.0075 |
| Cryo-Cell International, Inc. | 0.0928 |
| Strata Critical Medical, Inc. | -0.0366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -27.47M |
| Revenue (Quarterly) | 149.00M |
| Total Expenses (Quarterly) | 176.47M |
| Enterprise Value | 1.863B |
| Gross Profit Margin (Quarterly) | 67.71% |
| Profit Margin (Quarterly) | -18.44% |
| Earnings Yield | -3.49% |
| Normalized Earnings Yield | -5.054 |